Apellis Pharmaceuticals Long Term Deferred Assets (Quarterly) Analysis

Apellis Pharmaceuticals, Inc. (APLS)

21.01 +0.54 (+2.64%) USD | NASDAQ | Jan 21, 10:29

View Long Term Deferred Assets (Quarterly) for APLS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Amicus Therapeutics, Inc.	--
Alnylam Pharmaceuticals, Inc.	Upgrade
Ionis Pharmaceuticals, Inc.	--
Fortress Biotech, Inc.	--
Sarepta Therapeutics, Inc.	--